Is the management of hepatitis C patients appropriate? A population‐based study
- 5 April 2005
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 21 (8) , 1007-1015
- https://doi.org/10.1111/j.1365-2036.2005.02393.x
Abstract
Summary: Background : In order for hepatitis C patients to receive antiviral treatment, they must reach medical care.Aim : To assess the proportion of patients reaching medical care after hepatitis C diagnosis in a general population (1 006 171 inhabitants) in France.Methods : Between 1994 and 1999, 1508 cases were diagnosed, of which 1251 were eligible for the study.Results : Two‐hundred and two patients did not have any medical care; among them, 55.4% had normal alanine transferase, 58.4% had risk factors related to lifestyle and 22.8% were alcoholics. Amongst the 1049 other patients, 41.6% had a liver biopsy, 25.0% were treated. Treatment was more often carried out in males than in females (OR: 1.59; P = 0.001), and in patients under 65 than in older patients (OR: 2.22; P < 0.008). Among non‐treatment reasons, alcoholism (P = 0.001), drug‐addiction (P = 0.04) and escaping monitoring (P = 0.04) were more frequent in males than in females, whereas normal alanine transferase was more frequent in females than in males (P = 0.004). Amongst 278 patients with a Metavir score >A1F1, 71 (25.5%) did not undergo treatment.Conclusion : In a general population, one patient in six did not receive on‐going health care; a quarter of patients with a Metavir score >A1F1 did not receive any treatment. These results showed insufficient clinical management, which could compromise the effectiveness of treatment in general population.Keywords
This publication has 14 references indexed in Scilit:
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001
- Estimating future hepatitis C morbidity, mortality, and costs in the United StatesAmerican Journal of Public Health, 2000
- Epidemiology of hepatitis C in the United StatesThe American Journal of Medicine, 1999
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis CHepatology, 1997
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis CHepatology, 1994
- Follow up of blood donors positive for antibodies to hepatitis C virusBMJ, 1994
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991